Prof. Peter Enzinger

MD
Director, Center for Esophageal and
Gastric Cancer Institute Physician,
Dana - Farber Associate Professor,
Harvard Medical School, USA

Peter C. Enzinger, is Director of the Center for Esophageal and Gastric Cancer at Dana-Farber/Brigham Cancer Center, a Harvard-affiliated hub advancing research and therapies for these cancers. He developed key drugs like irinotecan and ramucirumab, now standards of care. His work appears in top journals, including NEJM and Lancet Oncology. A Brown University graduate, Dr. Enzinger trained at Memorial Sloan-Kettering and was an NIH Senior Fogarty Fellow in Paris. He serves on the NCCN Esophageal and Gastric Cancers Panel and the NCI GI Intergroup Task Force.